Biography
Özge oversees product development at Massive Bio, ensuring our platform evolves to meet the real needs of patients and clinicians navigating the cancer treatment landscape. She is committed to creating intuitive, patient-centric features that simplify access to clinical trials and treatment information. She bridges the gap between user feedback, clinical evidence, and technology innovation.
Late-Stage Multiple Myeloma
JUNE 2023
First Signs of Colon Cancer
JUNE 2022
Chronic Lymphocytic Leukemia vs Multiple Myeloma
JUNE 2022
What Is ROS1-Positive Non-small Cell Lung Cancer?
APRIL 2022
Stem Cell Transplant for Myelofibrosis
APRIL 2022
What Is a Biomarker? How Is It Used in Clinical Trials?
FEBRUARY 2022
What are the Differences Between Small Cell and Non-Small Cell Lung Cancer?
FEBRUARY 2022
Chronic Myelogenous Leukemia Treatment
JANUARY 2022
Diffuse Large B-Cell Lymphoma Stage 4
JANUARY 2022
Chemotherapy for Non-Hodgkin’s Lymphoma
JANUARY 2022
Myelofibrosis Prognosis
AUGUST 2021
What Causes Pancreatic Cancer?
JUNE 2021
Access of Right Treatments to the Right Patients in Oncology
FEBRUARY 2021
Are Pancreatic Cancer Clinical Trials Effective?
JANUARY 2021
Non-Small Cell Lung Cancer MET-Amplified Clinical Trials
JANUARY 2021
Colon Cancer Symptoms
NOVEMBER 2020
Small Cell Lung Cancer Symptoms
OCTOBER 2020
Advanced Cervical Cancer Treatment
JULY 2020
New Artificial Intelligence Based Cancer Clinical Trial Finder Mobile App
JULY 2020
Metastatic Breast Cancer Treatment
JUNE 2020
Patient Support in Precision Cancer Care
JANUARY 2020
Bladder Cancer Awareness
MAY 2018
No articles match your search.